(CNN) — The US Food and Drug Administration approved the first nasal spray epinephrine drug for severe allergic reactions known as anaphylaxis, providing a needle-free alternative to EpiPens and ...

Intranasal epinephrine was administered within 1 minute of identifying the reaction or when the patient returned to the clinic, which was within 20 minutes of immunotherapy treatment in half and 30-90 ...

SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves ...

The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...

Epinephrine now available in a nasal spray formulation (neffy) is being hailed as a way to diminish barriers to use, which is critical in emergency situations such as an anaphylactic reaction. The ...

The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...

Findings accepted for publication in the official journal of the American College of Allergy, Asthma and Immunology About 9 out of every 10 patients experiencing anaphylaxis were effectively treated ...

ARS Pharmaceuticals, Inc. has announced the filing for approval of neffy® (epinephrine nasal spray) 2 mg in Canada and the United Kingdom, where it will be marketed as EURneffy®. This follows neffy's ...

This month, the FDA approved a nasal spray version of the drug epinephrine, a potentially ground-breaking alternative to auto-injectors like EpiPen for people with serious allergies. The nasal spray, ...

Please provide your email address to receive an email when new articles are posted on . Nasal spray offers an alternative for patients who are afraid of needles. Participants absorbed epinephrine more ...